£95.00
Additional information
| Water Retention | Minimal |
|---|---|
| Hepatotoxicity | Unknown, but potential risk due to lack of comprehensive studies |
| Lab Test | Detection via specific drug tests for GW-0742 in anti-doping labs |
| Also known as | GW0742, GW 0742 |
| Blood pressure | Potential to lower blood pressure |
| Trade name | Not commercially available under a specific trade name |
| Storage conditions | Store at room temperature, away from moisture and light |
| Chemical name | {4-[({2-[3-fluoro-4-(trifluoromethyl)phenyl]propan-2-yl}amino)thiazol-5-yl]methylsulfanylphenoxy}acetic acid |
| Formula | C21H17F4NO3S2 |
| Substance class | PPARОґ (Peroxisome Proliferator-Activated Receptor delta) agonist |
| Main action | Activates PPARОґ receptors, enhancing energy metabolism and endurance |
| Half-life | Approximately 24 hours |
| Dosage (medical) | Not established for medical use |
| Dosage (sports) | 5-10 mg daily |
| Effects | Increased endurance, enhanced fat burning, improved lipid profile |
| Side effects | Potential long-term effects on cardiovascular health, unknown safety profile |
| Use in sports | Used illicitly for enhancing athletic performance, particularly in endurance sports |
| Manufacturer | Pharmaceutical |
